Seroprevalence of rubella virus, varicella zoster virus, cytomegalovirus and parvovirus B19 among pregnant women in the Sousse region, Tunisia;Séroépidémiologie de la rubéole, de la varicelle et des infections par le cytomégalovirus et le parvovirus B19 chez les femmes enceintes dans la région de Sousse, Tunisie

Bulletin de la Societe de Pathologie Exotique

Volumn 104, Issue 1, 2011, Pages 62-67

  Hannachi, N ^a   Marzouk, M ^a   Harrabi, I ^b   Ferjani, A ^a   Ksouri, Z ^a   Ghannem, H ^b   Khairi, H ^b   Hidar, S ^b   Boukadida, J ^a  

^a Laboratoire de Microbiologie Immunologie   (Tunisia)

^b FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Cytomegalovirus; History of eruption; Maghreb; Maternity hospital; Northern Africa; Parvovirus B19; Pregnant; Prevalence; Risk factors; Rubella virus; Sousse; Tunisia; Varicella zoster virus

Indexed keywords

VIRUS ANTIBODY;

ADULT; ARTICLE; BLOOD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPIDEMIOLOGY; FEMALE; HERPES ZOSTER; HOSPITAL; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOLOGY; PARVOVIRUS INFECTION; PREDICTIVE VALUE; PREGNANCY; PREGNANCY COMPLICATION; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; RUBELLA; RUBELLA VIRUS; SOCIOECONOMICS; STATISTICS; UNIVERSITY HOSPITAL; VARICELLA ZOSTER VIRUS; VERTICAL TRANSMISSION; VIROLOGY;

ADULT; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HOSPITALS, MATERNITY; HOSPITALS, UNIVERSITY; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; RUBELLA; RUBELLA VIRUS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 79952215647     PISSN: 00379085     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13149-010-0119-z     Document Type: Article

References (38)

1. Alanen A, Kahala K, Vahlberg T, et al (2005) Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 112(1):50-6 (Pubitemid 40095080)
2. Alfonsi V, Montomoli E, Manini I, et al (2007) Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? Vaccine 25(32):6086-8 [Epub 2007 June 4] (Pubitemid 47077545)
3. Ashrafunnessa, Khatun S, Islam MN, Chowdhury S (2000) Seroprevalence of rubella antibodies among antenatal population attending a tertiary level hospital in Dhaka City. Bangladesh Med Res Counc Bull 26(3):75-81 (Pubitemid 32791491)
4. Barah F, Chehada AG (2010) Prevalence of rubella IgG antibodies among Syrian females of childbearing age. Saudi Med J 31 (1):78-81
5. Caidi H, Bloom S, Azilmaat M, et al (2009) Rubella seroprevalence among women aged 15-39 years in Morocco. East Mediterr Health J 15(3):526-31
6. Clemens SA, Azevedo T, Fonseca JC, et al (1999) Seroepidemiology of varicella in Brazil: results of a prospective cross-sectional study. J Pediatr (Rio J) 75(6):433-41
7. el-Nawawy A, Soliman AT, el Azzouni O, et al (1996) Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area. J Trop Pediatr 42(3):154-7 (Pubitemid 26174524)
8. Elnifro E, Nisha AK, Almabsoot M, et al (2009) Seroprevalence of parvovirus B19 among pregnant women in Tripoli, Libya. J Infect Dev Ctries 3(3):218-20
9. Faye-Kette YH, Sylla-Koko DJ, Akoua-Koffi GC, et al (1993) Séroprévalence de la rubéole chez 461 femmes enceintes à Abidjan (Côte-d'Ivoire). Bull Soc Pathol Exot 86(3):185-7
10. Fillet AM, Lebon P (1999) Virus de la varicelle et du zona. In: Denis F (ed) Les virus transmissibles de la mère à l'enfant. John Libbey Eurotext, Paris, pp 240-51
11. Fowler KB, Stagno S, Pass RF, et al (1992) The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 326(10):663-7
12. Gargouri J, Elleuch H, Karray H, et al (2000) Prevalence of anti- CMV antibodies in blood donors in the Sfax region (value in blood transfusion). Tunis Med 78(8-9): 512-7
13. Ghebrekidan H, Rudén U, Cox S, et al (1999) Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol 12(1):53-64 (Pubitemid 29085537)
14. Gratacap-Cavallier B, Morand P, Dutertre N, et al (1998) Infection à cytomégalovirus chez la femme enceinte. Étude séroépidémiologique prospective chez 1 018 femmes en Isère. J Gynecol Obstet Biol Reprod (Paris) 27(2):161-6 (Pubitemid 28166189)
15. Haddad-Boubaker S, Ben Yahia A, Bahri O, Triki H (2004) Étude de l'infection par le virus de la rubéole chez l'enfant et l'adolescent en Tunisie. Pathol Biol (Paris) 52:11-5 (Pubitemid 38169424)
16. Khemiri B, Mahjoub S, Hmid RB, et al (1997) La séropré valence de la toxoplasmose et de la rubéole parmi une population de femmes enceintes consultant au CMNRT. Tunis Med 75:788-93 (Pubitemid 127511955)
17. Kurugol Z, Koturoglu G, Aksit S, Ozacar T (2007) Varicella seroprevalence in Turkish population in Cyprus. Acta Paediatr 96(6):861-3 [Epub 2007 April 27] (Pubitemid 46846901)
18. Laub R, Strengers P (2002) Parvoviruses and blood products. Pathol Biol (Paris) 50(5):339-48 (Pubitemid 34680096)
19. Letaïef M, Vanham G, Boukef K, et al (1997) Higher prevalence of parvovirus B19 in Belgian as compared to Tunisian blood donors: differential implications for prevention of transfusional transmission. Transfus Sci 18(4):523-30
20. Lin KH, You SL, Chen CJ, et al (1999) Seroepidemiology of human parvovirus B19 in Taiwan. J Med Virol 57(2):169-73
21. Lolekha S, Tanthiphabha W, Sornchai P, et al (2001) Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg 64 (3-4):131-6 (Pubitemid 32565840)
22. Marcelin AG, Soulié JC, Lefrère JJ, et al (1999) Parvovirus B19. In: Denis F (ed) Les virus transmissibles de la mère à l'enfant. John Libbey Eurotext, Paris, pp 289-304
23. Markenson GR, Yancey MK (1998) Parvovirus B19 infections in pregnancy. Semin Perinatol 22:309-17 (Pubitemid 28397552)
24. Marshall GS, Stout GG (2005) Cytomegalovirus seroprevalence among women of childbearing age during a 10-year period. Am J Perinatol 22(7):371-6 (Pubitemid 41463817)
25. Morinet F, Pallier C, Pillet S (2003) Parvoviridae. In: Huraux JM, Nicolas JC, Agut H, Peigue-Lafeuille H, Estem (eds) Traité de virologie médicale, Paris, pp 283-9
26. Nabli B (1970) Seroepidemiology of rubella in Tunisia. Bull World Health Organ 42(6):891-6
27. Nardone A, Tischer A, Andrews N, et al (2008) Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets. Bull World Health Organ 86 (2):118-25 (Pubitemid 351222526)
28. Palihawadana P, Wickremasinghe AR, Perera J (2003) Seroprevalence of rubella antibodies among pregnant females in Sri Lanka. Southeast Asian. J Trop Med Public Health 34(2):398-404 (Pubitemid 37141278)
29. Picone O, Grangeot-Keros L (2005) Rubéole et grossesse. EMC Gynecol Obstet 2(4):343-53
30. Plans P, Costa J, Espuñes J, et al (2007) Prevalence of varicellazoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age. BJOG 114(9):1122-7 (Pubitemid 47247032)
31. Ranger-Rogez S, Venot C, Aubart Y, et al (1999) Cytomégalovirus. In: Denis F (ed) Les virus transmissibles de la mère à l'enfant. John Libbey Eurotext, Paris, pp 214-39
32. Saadatian-Elahi M, Mekki Y, Del Signore C, et al (2007) Seroprevalence of varicella antibodies among pregnant women in Lyon- France. Eur J Epidemiol 22(6):405-9 [Epub 2007 May 30] (Pubitemid 47052083)
33. Stroffolini T, Ngatchu T, Chiaramonte M, et al (1993) Prevalence of cytomegalovirus seropositivity in an urban childhood population in Cameroon. New Microbiol 16(1):83-5
34. Tapia-Conyer R, Sepúlveda J, Salvatierra B, et al (1992) Determining factors of rubella in the 10 to 14 year-old population in Mexico. Salud Publica Mex 34(2):211-21
35. Trevisan A, Frasson C, Morandin M, et al (2007) Immunity against infectious diseases: predictive value of self-reported history of vaccination and disease. Infect Control Hosp Epidemiol 28(5):564-9 [Epub 2007 April 12] (Pubitemid 46814546)
36. Valeur-Jensen AK, Pedersen CB, Westergaard T, et al (1999) Risk factors for parvovirus B19 infection in pregnancy. JAMA 281(12):1099-105 (Pubitemid 29155886)
37. Wang IJ, Hwang KC, Tsai YH, et al (2006) Rubella seroprevalence among young women Taipei county after routine measles, mumps and rubella immunization program. Acta Paediatr Taiwan 47(1):14-7
38. Ziyaeyan M, Pourabbas B, Alborzi A, et al (2007) Prevalence of antibody to human parvovirus B19 in preschool age/young adult individuals in Shiraz, Iran. Pak J Biol Sci 10(10):1763-5 (Pubitemid 46607987)